These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 8593256

  • 1. Toxicokinetics of a single intravenous dose of rac-propranolol versus optically pure propranolol in the rat.
    Bode W, Toet AE, Stolker AA, van Ginkel LA, Groen K, Wemer J, de Wildt DJ.
    Chirality; 1995; 7(8):626-31. PubMed ID: 8593256
    [Abstract] [Full Text] [Related]

  • 2. The pharmacokinetics of etodolac enantiomers in the rat. Lack of pharmacokinetic interaction between enantiomers.
    Brocks DR, Jamali F.
    Drug Metab Dispos; 1990; 18(4):471-5. PubMed ID: 1976070
    [Abstract] [Full Text] [Related]

  • 3. The influence of aging on the stereoselective pharmacokinetics of propranolol in the rat.
    Vermeulen AM, Belpaire FM, Moerman E, de Smet F, Bogaert MG.
    Chirality; 1992; 4(2):73-9. PubMed ID: 1616826
    [Abstract] [Full Text] [Related]

  • 4. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers.
    Paradiso-Hardy FL, Walker SE, Bowles SK.
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):370-5. PubMed ID: 9707351
    [Abstract] [Full Text] [Related]

  • 5. Enantioselective inhibitory effect of nicardipine on the hepatic clearance of propranolol in man.
    Vercruysse I, Belpaire F, Wynant P, Massart DL, Dupont AG.
    Chirality; 1994 Jul; 6(1):5-10. PubMed ID: 8018468
    [Abstract] [Full Text] [Related]

  • 6. Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
    Lankford SM, Maskasame C, Bai SA.
    Drug Metab Dispos; 1994 Jul; 22(5):776-87. PubMed ID: 7835231
    [Abstract] [Full Text] [Related]

  • 7. Stereoselective pharmacokinetics of flobufen in rats.
    Trejtnar F, Wsol V, Szotakova B, Skalova L, Pavek P, Kuchar M.
    Chirality; 1999 Jul; 11(10):781-6. PubMed ID: 10561708
    [Abstract] [Full Text] [Related]

  • 8. Stereoselective differences in propranolol disposition in female Sprague-Dawley and Dark Agouti rats.
    Guttendorf RJ, Kostenbauder HB, Wedlund PJ.
    Drug Metab Dispos; 1991 Jul; 19(1):251-6. PubMed ID: 1673410
    [Abstract] [Full Text] [Related]

  • 9. Toxic doses of rac-, (-)-(S)- and (+)-(R)-propranolol in rats and rabbits.
    Toet AE, van de Kuil A, Vleeming W, Wemer J, Bode W, Meulenbelt J, de Wildt DJ.
    Chirality; 1996 Jul; 8(6):411-7. PubMed ID: 8904832
    [Abstract] [Full Text] [Related]

  • 10. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
    Suedee R, Bodhibukkana C, Tangthong N, Amnuaikit C, Kaewnopparat S, Srichana T.
    J Control Release; 2008 Aug 07; 129(3):170-8. PubMed ID: 18550193
    [Abstract] [Full Text] [Related]

  • 11. Dose-dependent stereopharmacokinetics of 5,6-dihydro-4H-4(isobutylamino)thieno(2,3-B)thiopyran-2-sulfonamide-7,7 -dioxide , a potent carbonic anhydrase inhibitor, in rats.
    Lin JH, Ulm EH, Los LE.
    Drug Metab Dispos; 1991 Aug 07; 19(1):233-8. PubMed ID: 1673405
    [Abstract] [Full Text] [Related]

  • 12. Stereoselective pharmacokinetics of ibuprofen in rats: effect of enantiomer-enantiomer interaction in plasma protein binding.
    Itoh T, Maruyama J, Tsuda Y, Yamada H.
    Chirality; 1997 Aug 07; 9(4):354-61. PubMed ID: 9275314
    [Abstract] [Full Text] [Related]

  • 13. Disposition kinetics of ML-1035 sulfoxide enantiomers and the prochiral sulfide in rats.
    Kuo BS, Poole JC, Mandagere AK, Hwang KK.
    Chirality; 1993 Aug 07; 5(6):428-35. PubMed ID: 8398602
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic data of propranolol enantiomers in a comparative human study with (S)- and (R,S)-propranolol.
    Lindner W, Rath M, Stoschitzky K, Semmelrock HJ.
    Chirality; 1989 Aug 07; 1(1):10-3. PubMed ID: 2642031
    [Abstract] [Full Text] [Related]

  • 15. Stereoselective disposition of propranolol in rabbits. Role of presystemic organs and dose.
    Marier JF, Pichette V, du Souich P.
    Drug Metab Dispos; 1998 Feb 07; 26(2):164-9. PubMed ID: 9456303
    [Abstract] [Full Text] [Related]

  • 16. Plasma protein binding of propranolol enantiomers as a major determinant of their stereoselective tissue distribution in rats.
    Takahashi H, Ogata H, Kanno S, Takeuchi H.
    J Pharmacol Exp Ther; 1990 Jan 07; 252(1):272-8. PubMed ID: 2299595
    [Abstract] [Full Text] [Related]

  • 17. Interspecies differences in stereoselective protein binding and clearance of MK-571.
    Tocco DJ, deLuna FA, Duncan AE, Hsieh JH, Lin JH.
    Drug Metab Dispos; 1990 Jan 07; 18(4):388-92. PubMed ID: 1976057
    [Abstract] [Full Text] [Related]

  • 18. Evidence for the involvement of a pulmonary first-pass effect via carboxylesterase in the disposition of a propranolol ester derivative after intravenous administration.
    Imai T, Yoshigae Y, Hosokawa M, Chiba K, Otagiri M.
    J Pharmacol Exp Ther; 2003 Dec 07; 307(3):1234-42. PubMed ID: 14534358
    [Abstract] [Full Text] [Related]

  • 19. Protein binding of indobufen enantiomers: pharmacokinetics of free fraction-studies after single or multiple doses of rac-indobufen.
    Główka FK, Caldwell J.
    Chirality; 2002 Oct 07; 14(9):736-41. PubMed ID: 12237835
    [Abstract] [Full Text] [Related]

  • 20. Influence of severity of inflammation on the disposition kinetics of propranolol enantiomers in ketoprofen-treated and untreated adjuvant arthritis.
    Piquette-Miller M, Jamali F.
    Drug Metab Dispos; 1995 Feb 07; 23(2):240-5. PubMed ID: 7736918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.